| JXHS2400116 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2024-12-21 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd | | | view |
| JXHS2400115 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2024-12-21 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd | | | view |
| JYHB2400459 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-08-20 | | Glaxo Operations UK Ltd;GlaxoSmithKline Intellectual Property Development Ltd | | | view |
| JYHZ2400073 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2024-03-26 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JTH2400035 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Disposable Import Drug Application | 2024-03-04 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2400111 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2024-03-02 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2300730 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-12-19 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2300304 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2023-05-24 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2200313 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2022-06-21 | | Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | | | view |
| JYHB2002759 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | In Review | 2021-01-04 | view |
| JXHL2000354 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Intellectual Property Development Ltd | In Review | 2021-01-04 | view |
| JXHL2000355 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;GlaxoSmithKline Intellectual Property Development Ltd | In Review | 2021-01-04 | view |
| JYHB2001496 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2020-08-20 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | Filed | 2020-08-31 | view |
| JYHB2000236 | 氟替美维吸入粉雾剂 | fluticasone furoate;umeclidinium bromide;vilanterol | Powder for inhalation | Chemical Drugs | Supplementary Application | 2020-03-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxosmithkline Trading Services Ltd | Certificate Issued | 2020-06-19 | view |
